This is a Turkey news story, published by bianet: , that relates primarily to Health Ministry news.
For more Turkey news, you can click here:
more Turkey newsFor more women's health news, you can click here:
more women's health newsFor more news from bianet: , you can click here:
more news from bianet:Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like women's health news, you might also like this article about
gender hormone medications. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest hormone replacement therapy news, gender reassignment news, women's health news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
hormone medicationsbianet:
•Health
Health
56% Informative
Turkey 's Health Ministry has introduced new restrictions limiting access to hormone medications used in gender-affirming treatment for individuals under the age of 21 .
The restricted medications include testosterone-based drugs, gonadotropin-releasing hormone (GnRH) analogues, and estrogen products containing 2 mg or more of the hormone.
The directive cites the government’s “ Year of the Family ” campaign for 2025 as the justification for the restriction.
VR Score
41
Informative language
32
Neutral language
44
Article tone
formal
Language
English
Language complexity
78
Offensive language
likely offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links